CD86 and COVID-19: The decreased expression of the costimulatory receptor CD86 on moderate COVID-19 monocytes compared to healthy and mild COVID-19 patients, the increased expression of the inhibitory receptors TIM-323 compared to healthy individuals, and PD124 compared to mild COVID-19 monocytes suggest an altered activation profile skewed towards an inhibitory phenotype.